Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedVersion 2025-12-19 adds/updates the 'Study Status' entry in the record history for NCT01946204 (Revision: v3.3.3). The 'HHS Vulnerability Disclosure' link is removed in Revision: v3.3.2.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision history updated to include v3.3.2 and remove v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedNew history entry on 2025-11-12 shows a Study Status update. The accompanying 2025-11-06 entry references version 120.SummaryDifference0.4%

- Check62 days agoChange DetectedDifference0.0%

- Check76 days agoChange DetectedAdded date 2025-10-20 and a new 'Study Status' entry; removed 2025-09-15. Overall, minor metadata updates with no impact on core content or pricing.SummaryDifference0.6%

- Check91 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference7%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.